Shandong Boan Biotechnology Company., Limited. Class H ( ($HK:6955) ) has issued an announcement. Shandong Boan Biotechnology Co., Ltd. announced ...

US FDA grants interchangeability designation to Celltrion's denosumab biosimilars, Stoboclo and Osenvelt: Incheon, South Korea Friday, October 31, 2025, 10:00 Hrs [IST] Celltrion, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Amgen Inc. is conducting a Phase 4 ...

The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and XGEVA® (denosumab): Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo ...

Maryam Rashid Al Habsi, a mother of eight, was 29 weeks pregnant with her youngest child when she was diagnosed with breast cancer. What she thought was normal swelling linked to pregnancy, turned out ...

At 49, Derek Wilks was a picture of health. The accountant from Purley, in south London, had run marathons around the world and kept himself fit with regular training.

Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently shared thoughts on. Cramer said that the company needs to ...

Ronald Klein was biking around his neighborhood in North Wales, Pennsylvania, in 2006 and tried to jump a curb.

A chef who was diagnosed with an aggressive form of breast cancer after discovering a lump is urging all men to “check their chests”. Mat Kelly, 42, first discovered a lump in his chest last October ...

Medicare beneficiaries from high vs low SES counties were less likely to discontinue romosozumab during the COVID-19 lockdown.

Amgen AMGN reported third-quarter 2025 adjusted earnings of $5.64 per share, which beat the Zacks Consensus Estimate of $5.00 ...